Literature DB >> 11929035

Liver transplantation in children.

Mohamed Rela1, Anil Dhawan.   

Abstract

The results of liver transplantation has improved significantly in the last decade with one year survival figures close to 90% for children with chronic liver disease. This can be attributed to improvement in surgical techniques, better postoperative care and newer immunosuppresive drugs. As a result of this, increasing number of children are referred for transplantation with no significant increase in the number of solid organ donors. The earliest transplants in children were performed using organs from size matched pediatric donors. However, as the pediatric donor numbers were limited, liver reduction techniques were developed to transplant small children before deterioration. Increasing experience with reduced livers led to the development of split liver, living donor and auxiliary liver transplantation. Better management of immunosuppressive drugs and newer agents such as Mycophenolate Mofetil have reduced the incidence of graft loss due to chronic rejection and long-term renal toxicity. The goal for the future will remain to be transplantation without the use of long-term immunosuppression.

Entities:  

Mesh:

Year:  2002        PMID: 11929035     DOI: 10.1007/BF02859381

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  28 in total

1.  Living donor liver transplantation: an 8-year experience with 379 consecutive cases.

Authors:  Y Inomata; K Tanaka; S Uemoto; K Asonuma; H Egawa; T Kiuchi; S Fujita; M Hayashi
Journal:  Transplant Proc       Date:  1999 Feb-Mar       Impact factor: 1.066

2.  Survival, growth and quality of life in children after orthotopic liver transplantation: a 5 year experience.

Authors:  S E Chin; R W Shepherd; G J Cleghorn; M K Patrick; G Javorsky; E Frangoulis; T H Ong; G Balderson; Y Koido; H Matsunami
Journal:  J Paediatr Child Health       Date:  1991-12       Impact factor: 1.954

3.  Health-related quality of life in long-term survivors of pediatric liver transplantation.

Authors:  D E Midgley; T A Bradlee; C Donohoe; K P Kent; E M Alonso
Journal:  Liver Transpl       Date:  2000-05       Impact factor: 5.799

4.  Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type I.

Authors:  M Rela; P Muiesan; H Vilca-Melendez; A Dhawan; A Baker; G Mieli-Vergani; N D Heaton
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

5.  An analysis of liver transplant experience from 37 transplant centers as reported to Medicare.

Authors:  V E Kilpe; H Krakauer; R E Wren
Journal:  Transplantation       Date:  1993-09       Impact factor: 4.939

6.  Hepatic transplantation in children under 3 months of age: a single centre's experience.

Authors:  H Bonatti; P Muiesan; S Connelly; A Baker; G Mieli-Vergani; P Gibbs; N Heaton; M Rela
Journal:  J Pediatr Surg       Date:  1997-03       Impact factor: 2.545

7.  Liver transplantation in man. I. Observations on technique and organization in five cases.

Authors:  R Y Calne; R Williams
Journal:  Br Med J       Date:  1968-11-30

8.  Surgical complications in children after liver transplantation.

Authors:  R Bilik; M Yellen; R A Superina
Journal:  J Pediatr Surg       Date:  1992-11       Impact factor: 2.545

9.  Treatment of central nervous system B lymphoproliferative syndrome by local infusion of a B cell-specific monoclonal antibody.

Authors:  J L Stephan; F Le Deist; S Blanche; J Le Bidois; M Peuchmaur; A Lellouch-Tubiana; M Hirn; C Griscelli; A Fischer
Journal:  Transplantation       Date:  1992-08       Impact factor: 4.939

10.  Liver transplantation in children.

Authors:  R W Busuttil; P Seu; J M Millis; K M Olthoff; J R Hiatt; A Milewicz; B Nuesse; G el-Khoury; D Raybould; A Nyerges
Journal:  Ann Surg       Date:  1991-01       Impact factor: 12.969

View more
  1 in total

1.  Influence of intrauterine injection of rat fetal hepatocytes on rejection of rat liver transplantation.

Authors:  Yan-Ling Yang; Ke-Feng Dou; Kai-Zong Li
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.